Peptide record

TPDB22306

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB22306
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia Antifungipept CAFPdb dbAMP HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 14-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from Peptipedia, Antifungipept, CAFPdb, and other sources, with an available 3D structural model.
Sequence
KRLFKELLFSLRKY
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C89H145N23O19
ANDCQGHIMPTWV
L
1841.27
10.89
5
1
7
+4
2.23
-0.393
111.43
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
1490
0.81
2
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
1
E
0
Q
0
G
0
H
0
I
4
L
3
K
0
M
2
F
0
P
1
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 0 H: 0 I: 0 L: 4 K: 3 M: 0 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
14 reviewed residue count
C89H145N23O19 sequence-only estimate (linear, free termini)
1841.27 sequence-only estimate (linear, free termini)
10.89 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
2.23 sequence-only estimate (linear, free termini)
-0.393 sequence-only estimate (linear, free termini)
Evidence Records 5 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
89±12 µM
Hemolytic Cytotoxic
50% Hemolysis | 89±12 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
>108 µM
Hemolytic Cytotoxic
50% Hemolysis | >108 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
73±2.0 µM
Hemolytic Cytotoxic
50% Hemolysis | 73±2.0 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 4 Activity

Activity

50% Hemolysis
Toxicity
59±0.1 µM
Hemolytic Cytotoxic
50% Hemolysis | 59±0.1 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 5 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis